. 2023 Feb 28;30(1):82–91. doi: 10.21315/mjms2023.30.1.7

Table 2.

Cell viability (%) for ORL115 and ORL188

Concentration of MTJ (mg/mL)	24 h		48 h		72 h

	ORL115	ORL188	ORL115	ORL188	ORL115	ORL188
Control	100.0 (0.0)^A,X	100.0 (0.0)^A,X	100.0 (0.0)^A,X	100.0 (0.0)^A,X	100.0 (0.0)^A,X	100.0 (0.0)^A,X
12.5	93.6 ± (3.5)^AB,X	88.9 (6.7)^A,X	94.2 (2.1)^A,X	92.8 (0.1)^A,X	88.6 (8.8)^A,X	90.9 (12.5)^A,X
25.0	88.3 (4.7)^B,X	90.3 (9.2)^A,X	73.4 (3.0)^B,Y	64.7 (3.3)^B,Y	51.8 (2.1)^B,Z	53.7 (8.8)^B,Z
50.0	91.6 (6.3)^AB,X	71.6 (0.8)^B,X	70.00 (0.9)^B,Y	59.7 (7.9)^B,Y	31.30 (5.0)^C,Z	41.8 (4.7)^B,Z
100	63.90 (2.8)^C,X	52.7 (2.5)^C,X	39.70 (8.4)^C,Y	37.3 (5.0)^C,Y	25.90 (2.5)^C,Z	38.4 (3.7)^B,Y
200	19.20 (2.90)^D,X	13.3 (0.2)^D,X	13.6 (1.2)^D,Y	8.2 (1.1)^D,X	4.41 (1.10)^D,Y	6.2 (0.1)^C,X
lC₅₀ (mg/mL)	105.8	90.6	65.1	56.9	35.5	43.5

Notes: Values are expressed in mean (SD), n = 3. Different superscript letters (A,B,C,D) within the columns for each concentration indicates significantly difference (Tukey’s multiple comparisons test, P < 0.05). Different superscript letters (X,Y,Z) within the rows for each time interval indicates significant difference (Tukey’s multiple comparisons test, P < 0.05)